Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Cell Death & Disease (3)
Leukemia (2)
Nature Communications (2)
Oncogene (1)
Cell Death Discovery (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (7)
Amendments and Corrections (1)
Correspondence (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Cancer
Cell biology
Diseases
Medical research

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–9 of 9 results

Advanced filters: Author: Walter Aulitzky Clear advanced filters

Author Correction: Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis

Yael Aylon
Noa Furth
Moshe Oren
Amendments and CorrectionsOpen Access10 Jan 2023
Nature Communications

Volume: 14, P: 1
Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis

LATS1 is reported to regulate the transition of luminal-basal-like cell plasticity in breast cancer. Here the authors report that LATS1 limits the progression of luminal breast cancer by associating with NCOR1 nuclear corepressor to repress ERα-downregulated genes in luminal cells.

Yael Aylon
Noa Furth
Moshe Oren
ResearchOpen Access28 Nov 2022
Nature Communications

Volume: 13, P: 1-20
BCR – ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner

Nathalie Cambier
Rajesh Chopra
Andrew G Elefanty
Research26 Jan 1998
Oncogene

Volume: 16, P: 335-348
Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells

Markus Kleih
Kathrin Böpple
Frank Essmann
ResearchOpen Access07 Nov 2019
Cell Death & Disease

Volume: 10, P: 1-12
ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC

Kathrin Böpple
Yaara Oren
Walter E. Aulitzky
ResearchOpen Access24 Apr 2024
Cell Death & Disease

Volume: 15, P: 1-12
The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA

Sandra Weller
Astrid Toennießen
Frank Essmann
ResearchOpen Access20 Apr 2022
Cell Death Discovery

Volume: 8, P: 1-12
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial

Christoph Röllig
Hubert Serve
Gerhard Ehninger
ResearchOpen Access18 Feb 2021
Leukemia

Volume: 35, P: 2517-2525
The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA

Alina Muenchow
Sandra Weller
Frank Essmann
ResearchOpen Access24 Aug 2020
Cell Death & Disease

Volume: 11, P: 1-12
All common p210 and p190 Bcr-abl variants can be targeted by RNA interference

L Wohlbold
H van der Kuip
W E Aulitzky
Correspondence25 Nov 2004
Leukemia

Volume: 19, P: 290-292